Abstract:<div><p>Ginkgolide terpenoid lactones, including ginkgolides and bilobalide, are two crucial bioactive constituents of extract of <em>Ginkgo biloba</em> (EGb) which was used in the treatment of cardiovascular and cerebrovascular diseases. The aims of this study were to investigate the antioxidant effects and mechanism of ginkgolides (ginkgolide A (GA), ginkgolide B (GB), ginkgolide K (GK)) and bilobalide (BB) against oxidative stress induced by transient focal cerebral ischemia. In vitro, SH-SY5Y cells were exposed to oxygen-glucose deprivation (OGD) for 4 h followed by reoxygenation with ginkgolides and BB treatments for 6 h, and then cell viability, superoxide dismutase (SOD), and ROS were respectively detected using kit. Western blot was used to confirm the protein levels of hemeoxygenase-1 (HO-1), quinone oxidoreductase l (Nqo1), Akt, phosphorylated Akt (p-Akt), nuclear factor-E2-related factor2 (Nrf2), and phosphorylated Nrf2 (p-Nrf2). GB combined with different concentrations of LY294002 (PI3K inhibitor) were administrated to SH-SY5Y cells for 1 h after OGD, and then p-Akt and p-Nrf2 levels were detected by western blot. In vivo, 2 h of middle cerebral artery occlusion (MCAO) model was established, followed with reperfusion and GB treatments for 24 and 72 h. The infarct volume ratios were confirmed by TTC staining. The protein levels of HO-1, Nqo1, SOD1, Akt, p-Akt, Nrf2, and p-Nrf2 were detected using western blot and immunohistochemistry (IHC). Experimental data in vitro confirm that GA, GB, GK, and BB resulted in significant decrease of ROS and increase of SOD activities and protein levels of HO-1 and Nqo1; however, GB group had a significant advantage in comparison with the GA and GK groups. Moreover, after ginkgolides and BB treatments, p-Akt and p-Nrf2 were significantly upregulated, which could be inhibited by LY294002 in a dose-dependent manner, meanwhile, GB exhibited more effective than GA and GK. In vivo, TTC staining indicated that the infarct volume ratios in MCAO rats were dramatically decreased by GB in a dose-dependent manner. Furthermore, GB significantly upregulated the protein levels of HO-1, Nqo1, SOD, p-Akt, p-Nrf2, and Nrf2. In conclusion, GA, GB, GK, and BB significantly inhibited oxidative stress damage caused by cerebral ischemia reperfusion. Compared with GA, GK, and BB, GB exerts the strongest antioxidant stress effects against ischemic stroke. Moreover, ginkgolides and BB upregulated the levels of antioxidant proteins through mediating the Akt/Nrf2 signaling pathway to protect neurons from oxidative stress injury.</p></div>

Ginkgolide B Protects Against Ischemic Stroke Via Modulating Microglia Polarization in Mice

Ginkgolide B Reduces Neuronal Cell Apoptosis in the Hemorrhagic Rat Brain: Possible Involvement of Toll-like Receptor 4/nuclear Factor-Kappa B Pathway.

Ginkgetin Promotes M2 Polarization of Microglia and Exert Neuroprotection in Ischemic Stroke via Modulation of PPARγ Pathway

Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice

Ginkgo Diterpene Lactones Inhibit Cerebral Ischemia/reperfusion Induced Inflammatory Response in Astrocytes Via TLR4/NF-κB Pathway in Rats.

XQ-1H Protects Against Ischemic Stroke by Regulating Microglia Polarization Through PPARγ Pathway in Mice.

Multiple Mechanistic Models Reveal the Neuroprotective Effects of Diterpene Ginkgolides Against Astrocyte-Mediated Demyelination Via the PAF-PAFR Pathway.

Salidroside Provides Neuroprotection by Modulating Microglial Polarization after Cerebral Ischemia.

Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo

Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway

Neuroprotective effects of Gastrodia elata Blume on promoting M2 microglial polarization by inhibiting JNK/TLR4/T3JAM/NF-κB signaling after transient ischemic stroke in rats

Inhibition of NF-κB Activation is Associated with Anti-Inflammatory and Anti-Apoptotic Effects of Ginkgolide B in a Mouse Model of Cerebral Ischemia/reperfusion Injury

Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in A<sub>1-42</sub>-induced microglia cells

Ginkgolide B Protects Human Pulmonary Alveolar Epithelial A549 Cells from Lipopolysaccharide‐induced Inflammatory Responses by Reducing TRIM37‐mediated NF‐κB Activation

Brain-targeted Ginkgolide B-modified Carbonized Polymer Dots for Alleviating Cerebral Ischemia Reperfusion Injury

Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ1-42-induced microglia cells

Protective effects of Ginkgo biloba extract on cerebral ischemia and the responses of CD11b-immunoreactivity positive cells

Hmgb1-Triggered Inflammation Inhibition Of Notoginseng Leaf Triterpenes Against Cerebral Ischemia And Reperfusion Injury Via Mapk And Nf-Kappa B Signaling Pathways

Platelet Membrane-Encapsulated Ginkgolide B Biomimetic Nanoparticles for the Treatment of Ischemic Stroke

Regulation of microglia related neuroinflammation contributes to the protective effect of Gelsevirine on ischemic stroke

Genistein-3′-sodium sulfonate Attenuates Neuroinflammation in Stroke Rats by Down-Regulating Microglial M1 Polarization through α7nAChR-NF-κB Signaling Pathway